These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Optic pathway gliomas in children with and without neurofibromatosis 1. Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652 [TBL] [Abstract][Full Text] [Related]
24. Vision specific quality of life in children with optic pathway gliomas. Avery RA; Hardy KK J Neurooncol; 2014 Jan; 116(2):341-7. PubMed ID: 24197987 [TBL] [Abstract][Full Text] [Related]
25. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study. Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191 [TBL] [Abstract][Full Text] [Related]
27. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort. Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081 [TBL] [Abstract][Full Text] [Related]
28. Orbital optic nerve gliomas in children with neurofibromatosis type 1. Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147 [TBL] [Abstract][Full Text] [Related]
29. Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1. Shaikh F; Johnston D; Michaud J; Hurteau J; Vassilyadi M; Keene D Pediatr Blood Cancer; 2011 Oct; 57(4):688-6690. PubMed ID: 21465640 [TBL] [Abstract][Full Text] [Related]
30. The role of surgery in optic pathway/hypothalamic gliomas in children. Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145 [TBL] [Abstract][Full Text] [Related]
31. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma. Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625 [TBL] [Abstract][Full Text] [Related]
32. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [TBL] [Abstract][Full Text] [Related]
34. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review. Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769 [TBL] [Abstract][Full Text] [Related]